LY2828360

Overview

LY2828360 is a slowly acting but efficacious G protein-biased cannabinoid (CB 2 ) agonist, inhibiting cAMP accumulation and activating ERK1/2 signaling.

Application

Products | Products > Disease Areas > Prostate Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Pain | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Coronavirus Infection | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Cannabinoid Receptor

Product Information

• Catalog No.: HY-16642A
• CAS No.: 1231220-79-3
• Molecular Formula: C22H27ClN6O
• Molecular Weight: 426.94
• Purity: 99.50%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 1 mg/mL (2.34 mM); Clear solution
• Availability: In-stock

Source

Original product source